Literature DB >> 29207337

Quinoxaline: An insight into the recent pharmacological advances.

Sana Tariq1, K Somakala1, Mohd Amir2.   

Abstract

Quinoxaline, a fused heterocycle of benzene and pyrazine rings has gained considerable attention in the field of contemporary medicinal chemistry. The moiety is of substantial importance because of its wide array of pharmacological activities viz. anti-cancer, antimalarial, anti-inflammatory, antimicrobial, anti-HIV etc. Diversely substituted quinoxalines are important therapeutic agents in the pharmaceutical industry. This review focusses on the quinoxaline derivatives developed during the last decennial period and their biomedical applications. A compilation of patents on quinoxaline is also included herein.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-cancer; Anti-inflammatory; Antimalarial; Antimicrobial; Biological applications; Quinoxaline

Mesh:

Substances:

Year:  2017        PMID: 29207337     DOI: 10.1016/j.ejmech.2017.11.064

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  18 in total

1.  Synthesis of Morpholine-, Piperidine-, and N-Substituted Piperazine-Coupled 2-(Benzimidazol-2-yl)-3-arylquinoxalines as Novel Potent Antitumor Agents.

Authors:  Vakhid A Mamedov; Nataliya A Zhukova; Alexandra D Voloshina; Victor V Syakaev; Tat'yana N Beschastnova; Anna P Lyubina; Syumbelya K Amerhanova; Aida I Samigullina; Aidar T Gubaidullin; Daina N Buzyurova; Il Dar Kh Rizvanov; Oleg G Sinyashin
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-01

2.  New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.

Authors:  Ming-Hao Hu; Tian-Ying Wu; Qiong Huang; Guangyi Jin
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

3.  Antiviral Agents - Benzazine Derivatives.

Authors:  Nataliya N Mochulskaya; Emiliya V Nosova; Valery N Charushin
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-14       Impact factor: 1.490

4.  An approach to new chiral bicyclic imines and amines via Horner-Wadsworth-Emmons reaction.

Authors:  Jakub Iwanejko; Mateusz Sowiński; Elżbieta Wojaczyńska; Tomasz K Olszewski; Marcin Górecki
Journal:  RSC Adv       Date:  2020-04-09       Impact factor: 3.361

5.  Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.

Authors:  Marc Montana; Vincent Montero; Omar Khoumeri; Patrice Vanelle
Journal:  Molecules       Date:  2020-06-16       Impact factor: 4.411

6.  Dragon's Blood Sap: Storage Stability and Antioxidant Activity.

Authors:  Juan D Escobar; Cristina Prieto; Maria Pardo-Figuerez; José M Lagaron
Journal:  Molecules       Date:  2018-10-15       Impact factor: 4.411

7.  Synthesis of pyrimido[1,6-a]quinoxalines via intermolecular trapping of thermally generated acyl(quinoxalin-2-yl)ketenes by Schiff bases.

Authors:  Svetlana O Kasatkina; Ekaterina E Stepanova; Maksim V Dmitriev; Ivan G Mokrushin; Andrey N Maslivets
Journal:  Beilstein J Org Chem       Date:  2018-07-11       Impact factor: 2.883

8.  Construction of a novel quinoxaline as a new class of Nrf2 activator.

Authors:  Murugesh Kandasamy; Kit-Kay Mak; Thangaraj Devadoss; Punniyakoti Veeraveedu Thanikachalam; Raghavendra Sakirolla; Hira Choudhury; Mallikarjuna Rao Pichika
Journal:  BMC Chem       Date:  2019-09-24

9.  Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline.

Authors:  Sofia Balou; Athanasios Zarkadoulas; Maria Koukouvitaki; Luciano Marchiò; Eleni K Efthimiadou; Christiana A Mitsopoulou
Journal:  Bioinorg Chem Appl       Date:  2021-05-12       Impact factor: 7.778

10.  Crystal structure of 2,3-bis-(4-methyl-phen-yl)benzo[g]quinoxaline.

Authors:  Young-Inn Kim; Seong-Jae Yun; Sung Kwon Kang
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.